Prof. Roberto Canani
Chief of the Pediatric Allergy Program at the Department of Translational Medical Science and founder of the ImmunoNutritionLab at CEINGE Advanced Biotechnologies and Member of the Advisory Board of the European Laboratory for the Investigation of Food Induced Diseases at the University of Naples Federico II, Naples, Italy.
Member of many national and international scientific societies:
- Italian Society of Pediatrics
- Italian Society of Pediatric Gastroenterology Hepatology and Nutrition. Vice-president (2008-2012) and Chief of the food-induced diseases working group (from 2014)
- Italian Society of Pediatric Allergy and Immunology
- Italian Society of Infectious Diseases
- Italian Society of Pediatric Research
- European Academy of Allergy and Clinical Immunology. Member of the ImmunoNutritrion Working Group.
- European Society for Pediatric Gastroenterology Hepatology and Nutrition. Member of the Probiotics working group.
Founder and member of the Advisory Board of the Task Force on Microbiome Studies of the University of Naples Federico II.
Chief of the Pediatric Allergy Program at the Department of Translational Medical Science and founder of the ImmunoNutritionLab at CEINGE Advanced Biotechnologies and Member of the Advisory Board of the European Laboratory for the Investigation of Food Induced Diseases at the University of Naples Federico II, Naples, Italy.
Member of many national and international scientific societies:
- Italian Society of Pediatrics
- Italian Society of Pediatric Gastroenterology Hepatology and Nutrition. Vice-president (2008-2012) and Chief of the food-induced diseases working group (from 2014)
- Italian Society of Pediatric Allergy and Immunology
- Italian Society of Infectious Diseases
- Italian Society of Pediatric Research
- European Academy of Allergy and Clinical Immunology. Member of the ImmunoNutritrion Working Group.
- European Society for Pediatric Gastroenterology Hepatology and Nutrition. Member of the Probiotics working group.
Founder and member of the Advisory Board of the Task Force on Microbiome Studies of the University of Naples Federico II.
Prof. Roberto Berni Canani received his MD and PhD degrees from University of Naples Federico II, Naples, Italy. He is board certified in Pediatrics. Chief of the Pediatric Allergy Program at the Department of Translational Medical Science and founder of the ImmunoNutritionLab at CEINGE Advanced Biotechnologies, Univ. of Naples Federico II.
Prof. R. Berni Canani has developed an interdisciplinary research team and a highly integrated research clinical program to better understand the pathogenic mechanisms of GI diseases and provide the best care for children affected by these disorders. His research is focused on the identification of the best strategies for the management of pediatric GI disorders. He uses a bench to bedside approach to investigate pathophysiological basis of pediatric GI diseases including animal models, peripheral blood cells culture from children, epigenetics biomarkers involved regulation of GI and immune system function, gut microbiome structure and function analysis.
His studies on gut microbiome, probiotics, postbiotics, immune tolerance and immunonutrition have already been translated into novel concepts and lead to a paradigm shift in the pathogenesis and treatment of pediatric GI diseases.
He is author of more than 300 publications. His publications are widely quoted. Associate editor of World Journal of Gastroenterology, Journal of Pediatric Gastroenterology and Nutrition, Journal of Gastroenterology and Hepatology Research, Frontiers in Nutrition, Frontiers in Allergy, International Journal of Autoimmune Disease & Therapy.
Bruno C, et al.
Protective effects of the postbiotic deriving from cow's milk fermentation with L. paracasei CBA L74 against Rotavirus infection in human enterocytes.
Sci Rep. 2022;12(1):6268.
https://pubmed.ncbi.nlm.nih.gov/35428750/
De Filippis F. et al.
Specific gut microbiome signatures and the associated pro-inflamatory functions are linked to pediatric allergy and acquisition of immune tolerance.
Nat Commun. 2021 Oct 13;12(1):5958
https://pubmed.ncbi.nlm.nih.gov/34645820/
Paparo L, et al.
Protective effects elicited by cow milk fermented with L. paracasei CBAL74 against SARS-CoV-2 infection in human enterocytes.
J Funct Foods. 2021;87:104787.
https://pubmed.ncbi.nlm.nih.gov/34630633/
Aguilar-Toalá JE, et al.
Postbiotics - when simplification fails to clarify.
Nat Rev Gastroenterol Hepatol. 2021;18(11):825-826.
https://pubmed.ncbi.nlm.nih.gov/34556825/
Berni Canani R, et al.
Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract.
Front Pediatr. 2021;9:697390.
https://pubmed.ncbi.nlm.nih.gov/34395341/
Nocerino R, et al.
Efficacy of ginger as antiemetic in children with acute gastroenteritis: a randomised controlled trial.
Aliment Pharmacol Ther. 2021;54(1):24-31.
https://pubmed.ncbi.nlm.nih.gov/34018223/
Paparo L, et al.
Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection.
Sci Rep. 2020;10(1):12636.
https://pubmed.ncbi.nlm.nih.gov/32724066/
Roggero P, et al.
Analysis of immune, microbiota and metabolome maturation in infants in a clinical trial of Lactobacillus paracasei CBA L74-fermented formula.
Nat Commun. 2020;11(1):2703.
https://pubmed.ncbi.nlm.nih.gov/32483147/
Prof. Roberto Canani’s Microbiota Events
Beneficial effects of probiotics to avoid antibiotics side effects.
